| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.25 | 7e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |